GNH USA

Europe — EMA

Olmesartan/Amlodipine Krka (Olmesartan Medoxomil, Amlodipine)

GNH USA supplies Olmesartan/Amlodipine Krka (Olmes4 ... ), ... .... ... ... … … … … … … … … … … … … ...

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil, Amlodipine?

Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipine Krka, is an ARB presented as a strength/form for oral use. It treats hypertension, often in combination with other antihypertensive agents, and is suitable for adult patients. GNH USA supplies Olmesartan/Amlodipine Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan/Amlodipine Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil, Amlodipine used for?

Olmesartan/Amlodipine combines a renin‑angiotensin system blocker with a calcium‑channel blocker to manage high blood pressure.

- Hypertension: improves blood pressure control when monotherapy is insufficient. - Hypertensive heart disease: reduces cardiac workload and risk of progression. - Chronic kidney disease with hypertension: slows renal function decline associated with high blood pressure.

What are the side effects of Olmesartan Medoxomil, Amlodipine?

Side effects may vary in frequency and severity.

Common Side Effects: - Dizziness - Peripheral edema - Headache - Flushing - Fatigue - Nausea

Serious or Rare Side Effects: - Angio‑edema - Severe hypotension - Hepatic dysfunction - Myocardial infarction - Arrhythmias - Acute kidney injury

What precautions apply to Olmesartan Medoxomil, Amlodipine?

When prescribing Olmesartan/Amlodide, clinicians should consider several safety aspects.

- Monitor blood pressure: ensure adequate control without excessive lowering. - Assess renal function: adjust use in patients with impaired kidneys. - Check electrolytes: watch for potassium abnormalities. - Review concomitant antihypertensives: avoid additive hypotensive effects. - Pregnancy: contraindicated in the second and third trimesters. - Store at below 25°C: keep in the original packaging and protect from moisture.

What does Olmesartan Medoxomil, Amlodipine interact with?

Olmesartan/Amlodipine may interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid): - Potassium‑rich supplements/diuretics: increase risk of hyper‑kalemia. - Strong CYP3A4 inhibitors (e.g., ketoconazole): raise amlodipine levels. - NSAIDs: may blunt antihypertensive response and affect renal function.

Moderate Interactions (Monitor Closely): - Other antihypertensives: risk of additive hypotension. - Lithium: monitor serum levels for toxicity. - Rifampin: may reduce amlodipine exposure.

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil, Amlodipine
Route
Oral Use
Manufacturer
Krka, D.D., Novo Mesto
Origin
EU

Related products